Next Article in Journal
Hemmule: A Novel Structure with the Properties of the Stem Cell Niche
Previous Article in Journal
Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs
Previous Article in Special Issue
Pisidium coreanum Inhibits Multinucleated Osteoclast Formation and Prevents Estrogen-Deficient Osteoporosis
Open AccessArticle

A Sub-Clone of RAW264.7-Cells Form Osteoclast-Like Cells Capable of Bone Resorption Faster than Parental RAW264.7 through Increased De Novo Expression and Nuclear Translocation of NFATc1

1
Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Alfred Nobels Allé, 8, SE-141 52 Stockholm, Sweden
2
Musculoskeletal Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB 252ZD, UK
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(2), 538; https://doi.org/10.3390/ijms21020538
Received: 9 December 2019 / Revised: 7 January 2020 / Accepted: 10 January 2020 / Published: 14 January 2020
(This article belongs to the Special Issue Osteoclast Multinucleation Mechanisms)
The murine macrophage cell line RAW264.7 is extensively used as a progenitor to study osteoclast (OC) differentiation. RAW264.7 is a heterogeneous cell line, containing sub-clones with different abilities to form OCs. The aim of this study was to identify characteristics within the heterogeneous RAW264.7 cells that define sub-clones with an augmented ability to form bone-resorbing OCs (H9), as well as sub-clones representing non-OCs (J8). RAW264.7 sub-clones were isolated by single cell cloning. Selection was based on TRAP/cathepsin K expression in sub-clone cultures without added RANKL. Sub-clones before and after differentiation with RANKL were assayed for multiple OC-characteristics. Sub-clone H9 cells presented a higher expression of OC-markers in cultures without added RANKL compared to the parental RAW264.7. After 6 days of RANKL stimulation, sub-clone H9 cells had equal expression levels of OC-markers with RAW264.7 and formed OCs able to demineralize hydroxyapatite. However, sub-clone H9 cells displayed rapid differentiation of OC already at Day 2 compared to Day 4 from parental RAW264.7, and when cultured on plastic and on bone they were more efficient in resorption. This rapid differentiation was likely due to high initial expression/nuclear translocation of OC master transcription factor, NFATc1. In contrast to H9, J8 cells expressed initially very low levels of OC-markers, and they did not respond to RANKL-stimulation by developing OC-characteristics/OC-marker expression. Hence, H9 is an additional clone suitable for experimental setup requiring rapid differentiation of large numbers of OCs. View Full-Text
Keywords: Osteoclast; RAW264.7; tartrate-resistant acid phosphatase; osteoclastogenesis; bone resorption; NFATc1; differentiation Osteoclast; RAW264.7; tartrate-resistant acid phosphatase; osteoclastogenesis; bone resorption; NFATc1; differentiation
Show Figures

Graphical abstract

MDPI and ACS Style

Mira-Pascual, L.; Tran, A.N.; Andersson, G.; Näreoja, T.; Lång, P. A Sub-Clone of RAW264.7-Cells Form Osteoclast-Like Cells Capable of Bone Resorption Faster than Parental RAW264.7 through Increased De Novo Expression and Nuclear Translocation of NFATc1. Int. J. Mol. Sci. 2020, 21, 538.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop